Biotech News

Avalon GloboCare Appoints Seasoned AI and Finance Executive as Chief Financial Officer

Avalon GloboCare (AVCO)Avalon GloboCare2026-06-25 13:46 ESTCompany update

AVCO (AVCO) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is avco.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Open original release

Related news

AVCOAvalon GloboCare2026-06-25 13:46 EST

Chief Patrick Flannelly Highlights KetoAir™ Progress in Supporting the Nevada First Responders Holistic Health Reset Program

AVCOAvalon GloboCare2026-06-25 13:46 EST

Avalon GloboCare Regains Compliance with Nasdaq Stockholders’ Equity Requirement, Launches Marketing for Automated Generative AI Video Platform

AVCOAvalon GloboCare2026-06-25 13:46 EST

Avalon GloboCare Announces FDA Registration Renewal for KetoAir™ and Planned B2B and B2C Launch Through Catch-Up™, Its Automated Generative AI-Powered Short-Form Video SaaS Platform

AVCOAvalon GloboCare2026-06-25 13:46 EST

Avalon GloboCare’s Subsidiary Files AI Patent Targeting Compliance-Ready Automated Video Commentary

AVCOAvalon GloboCare2026-06-25 13:46 EST

Avalon GloboCare Eliminates Majority of Debentures Through $2.6 Million Conversion, Strengthening Balance Sheet, Reduces Overhang

AVCOAvalon GloboCare2026-06-25 13:46 EST

Avalon GloboCare’s Subsidiary Files Third U.S. Provisional Patent for its Catch-Up Generative AI Video Platform

AVCOAvalon GloboCare2026-06-25 13:46 EST

Avalon GloboCare’s Subsidiary Accepted into AMD AI Developer Program to Advance Next-Generation Media Infrastructure

AVCOAvalon GloboCare2026-06-25 13:46 EST

Avalon GloboCare Announces up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules

AVCOAvalon GloboCare2026-06-25 13:46 EST

Avalon GloboCare Announces Closing of up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules

AVCOAvalon GloboCare2026-06-25 13:46 EST

Avalon Quantum AI Announces Strategic Collaboration with Caylent, an Amazon Web Services Premier Tier Partner, to Advance its Catch-Up Product into a Fully Autonomous Agentic AI Video Platform

View all latest news

Avalon GloboCare

Avalon GloboCare is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

AVCOAvalon GloboCare2026-06-26 08:47 EST

Chief Patrick Flannelly Highlights KetoAir™ Progress in Supporting the Nevada First Responders Holistic Health Reset Program

AVCOAvalon GloboCare2026-06-26 08:47 EST

Avalon GloboCare Appoints Seasoned AI and Finance Executive as Chief Financial Officer

AVCOAvalon GloboCare2026-06-26 08:47 EST

Avalon GloboCare Regains Compliance with Nasdaq Stockholders’ Equity Requirement, Launches Marketing for Automated Generative AI Video Platform

AVCOAvalon GloboCare2026-06-26 08:47 EST

Avalon GloboCare Announces FDA Registration Renewal for KetoAir™ and Planned B2B and B2C Launch Through Catch-Up™, Its Automated Generative AI-Powered Short-Form Video SaaS Platform

AVCOAvalon GloboCare2026-06-26 08:47 EST

Avalon GloboCare’s Subsidiary Files AI Patent Targeting Compliance-Ready Automated Video Commentary

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States